Position in JNJ
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$279,113
-$10,548 QoQ
Shares Held
1,099
-7.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.79%
of 13F equity value
Holder Rank
#4,225
of 4,664 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kings Path Partners LLC holds $684,839 across 5 Drug Manufacturers - General names. JNJ ranks #2 (40.8% of the industry book) .
All Filings in JNJ
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $279,113 | 1,099 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $289,661 | 1,185 | Shares | Sole | 2026-08-21 | |
| 2025-12-31 | $245,235 | 1,185 | Shares | Sole | 2026-07-14 | |
| 2025-09-30 | $219,722 | 1,185 | Shares | Sole | 2026-07-13 | |
| 2025-06-30 | $181,008 | 1,185 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $196,520 | 1,185 | Shares | Sole | 2025-04-04 | |
| 2024-12-31 | $1,233,319 | 8,528 | Shares | Sole | 2025-01-06 | |
| 2024-09-30 | $1,382,047 | 8,528 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $1,246,452 | 8,528 | Shares | Sole | 2024-07-30 | |
| No filing history on record for this holder in this stock. | ||||||